Tennessee Oncology PLLC- Centennial Medical Center
Nashville, Tennessee, United States
Oncologist in Nashville, Tennessee
250 25th Ave N #412, Nashville, TN 37203
About Tennessee Oncology PLLC- Centennial Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
3
Novartis Pharmaceuticals
3
Gynecologic Oncology Group
2
Takeda
2
Akeso
1
Alliance for Clinical Trials in Oncology
1
Arcus Biosciences, Inc.
1
BeiGene
1
Dendreon
1
Denovo Biopharma LLC
1
ECOG-ACRIN Cancer Research Group
1
Clinical Trials at Tennessee Oncology PLLC- Centennial Medical Center
During the past decade, Tennessee Oncology PLLC- Centennial Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on
average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
2007-07-31
2019-08-21
Completed
846
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
2009-04-01
2013-02-01
Completed
452
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
2009-03-23
Unknown status
601
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
2009-06-29
2024-07-28
Active, not recruiting
813
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
2010-06-01
Active, not recruiting
2,527
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tennessee Oncology PLLC- Centennial Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Novartis Pharmaceuticals" with 3 trials
sponsored, "Gynecologic Oncology Group" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Akeso"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology PLLC- Centennial Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Akesobio Australia Pty Ltd" with 1 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Tennessee Oncology PLLC- Centennial Medical Center
According to Clinical.Site data, the most researched conditions in "Tennessee Oncology PLLC- Centennial Medical Center" are
"Colorectal Cancer" (2 trials), "Endometrial Clear Cell Adenocarcinoma" (2 trials), "Endometrial Serous Adenocarcinoma" (2 trials), "Stage II Uterine Corpus Cancer AJCC v7" (2 trials) and "Adenocarcinoma of the Colon" (1 trials). Many other conditions were trialed in "Tennessee Oncology PLLC- Centennial Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Tennessee Oncology PLLC- Centennial Medical Center
Most popular intervention types in "Tennessee Oncology PLLC- Centennial Medical Center" are "Drug" (17 trials), "Other" (6 trials), "Biological" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (4 trials), "Laboratory Biomarker Analysis" (3 trials), "Paclitaxel" (3 trials), "oxaliplatin" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Tennessee Oncology PLLC- Centennial Medical Center
The vast majority of trials in "Tennessee Oncology PLLC- Centennial Medical Center" are
13 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Tennessee Oncology PLLC- Centennial Medical Center
Currently, there are NaN active trials in "Tennessee Oncology PLLC- Centennial Medical Center".
undefined are not yet recruiting,
3 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Tennessee Oncology PLLC- Centennial Medical Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Tennessee Oncology PLLC- Centennial Medical Center, 3 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".